Skip to main content
Contact Us
Subscriber Sign In
navigation
サイト内検索
What We Do
Commercial Intelligence
Products
Evaluate Pharma
Evaluate Omnium
Evaluate Medtech
Evaluate Epi
Japan Drug Forecasts
Europe Drug Forecasts
CDMO Intelligence
Pharma Consulting & Analytics
Pharma Consulting & Analytics
Data Feeds
Evaluate Vantage
News
Analysis
Policy & Pricing
Insights
Events
Medtech
Therapy Areas
Evaluate for Biotech
How We Can Help You
Pharma and Biotech
Financial Services
Management Consultancies
Service Providers
Customer Testimonials
Thought Leadership
Multimedia
Blog
About Us
Press Releases
Media Coverage
Executive Team
Vision & History
Contact Us
Sign Up for Evaluate Vantage
Talent
Subscriber Sign In
Search
Open configuration options
Search
Vantage
News
Snippets
Deals
Trial results
Patents and litigation
Corporate strategy
Analysis
Interviews
Spotlight
Vantage points
Vantage views
Insights
M&A
IPO
NME approvals
Quarterly shareprice performance
Venture financing
Vantage data points
Other data
Events
Company events
Conferences
Upcoming events
Medtech
Therapy Areas
Breadcrumb
Home
Vantage
Pharmaceutical Companies
Aventis
Evaluate
July 10, 2014
Sanofi and Regeneron itching to move dupilumab into phase III
June 18, 2014
Big pharma becomes a smaller employer as biotech booms
September 20, 2012
Questcor’s Acthar fairy tale goes sour
August 28, 2012
Pascal Soriot answers AstraZeneca’s 911 call
November 16, 2011
AHA 2011 – HDL’s role as bystander or risk factor still unclear
October 31, 2011
Pfizer to lose crown to Sanofi as world’s biggest drug maker
August 25, 2011
Shire loses with Dermagraft and wins with Firazyr
April 27, 2011
Regeneron, Sanofi finally get an aflibercept cancer win
November 04, 2010
Therapeutic focus – Novartis set to dominate meningitis vaccine market
August 02, 2010
Therapeutic focus – ALS field entering pivotal stage
July 22, 2010
Which big pharma remains hostage to blockbuster fortune?
Load More
Latest Reports
July 27, 2023
H1 Round Up: The haves and the have-nots
July 21, 2023
ADA/EASL eBook
Editor's Picks
July 03, 2023
Astrazeneca and Daiichi’s big reveal disappoints
July 13, 2023
Pharma finds a way to gain weight
July 03, 2023
Protagonist investors flake as psoriasis pill disappoints
June 29, 2023
Approaching datasets for big pharma
June 27, 2023
Nkarta goes back to basics
